1. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study Ashizawa, Tetsuo; Figueroa, Karla; Perlman, Susan; Gomez, Christopher; Wilmot, George; Schmahmann, Jeremy; Ying, Sarah; Zesiewicz, Theresa; Paulson, Henry; Shakkottai, Vikram; Bushara, Khalaf; Kuo, Sheng-Han; Geschwind, Michael; Xia, Guangbin; Mazzoni, Pietro; Krischer, Jeffrey; Cuthbertson, David; Holbert, Amy; Ferguson, John; Pulst, Stefan; Subramony, SH 2013 Articles Cerebellar ataxiaTherapeuticsClinical trialsClinical trials--DesignCerebellum--DiseasesRare diseases--ResearchFriedreich's ataxiaMedicine
2. Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) Reduce the Expression of Toll-Like Receptor 4 in Mice with Alcoholic Liver Disease Hong, Meegun; Kim, Seung Woo; Han, Sang Hak; Kim, Dong Joon; Suk, Ki Tae; Kim, Yeon Soo; Kim, Myong Jo; Kim, Moon Young; Baik, Soon Koo; Ham, Young Lim 2015 Articles Alcoholic liver diseasesGinseng--Therapeutic useUrushiolEndotoxinsTherapeuticsProbioticsMedicineToxicologyPathologyPharmacology
3. Key principles to accelerate progress in noncommunicable disease care and treatment: Discussion Paper Greene, Kate; Sakolsky, Natasha; Daly, Jessica; Dirks, Rebecca; Kekihembo, Constance; Rabkin, Miriam; White, Heather 2016 Reports TherapeuticsDisease managementCommunity health servicesChronic diseasesMedicineHealth services administrationMedical care
4. Development of Novel Therapeutics for Timothy Syndrome Using Human Induced Pluripotent Stem Cells Song, Loujin 2017 Theses PharmacologyHeart--DiseasesStem cellsTherapeuticsMedicine